Anna Gloyn is currently Professor of Pediatrics and Genetics at Stanford University. She trained at the Universities of Oxford, Exeter and Pennsylvania. The consistent focus of her research has been using naturally occurring mutations in humans as tools to identify critical regulatory pathways and insights into normal physiology and to translate this information into improvements in clinical care.
(Full: Anna Gloyn is currently Professor of Pediatrics and by Courtesy Genetics at Stanford University. The consistent focus of her research has been using naturally occurring mutations in humans as tools to identify critical regulatory pathways and insights into normal physiology and to translate this information into improvements in clinical care. Anna's research is focused on diabetes and includes both monogenic varieties and type 2 diabetes. Her group uses a variety of complementary approaches working both a scale (genome-wide) and specific loci and includes human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis. She is involved in a number of international efforts to interpret variation in genes with known roles in monogenic diabetes and is a member of the Clin Gen Monogenic Diabetes Variant Curation Expert Panel and the American Diabetes Association Precision Medicine Consensus Working Group for Precision Diagnostics for Monogenic Diabetes).
Personal Website
https://med.stanford.edu/genomics-of-diabetes.html
Teams
Executive Committee